ARTICLE | Company News
Viscum other research news
March 25, 2002 8:00 AM UTC
Viscum received a 4-year E2.55 million ($2.25 million) grant from the German Ministry of Education and Research to develop cancer therapeutics based on cancer-directed toxin fusion proteins. ...